![Andrew Saik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Saik
Directeur Financier/CFO chez
ARVINAS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Andrew R.
Saik is currently an Independent Non-Executive Director at Milestone Pharmaceuticals, Inc. since 2024 and Chief Financial Officer & Treasurer at Arvinas, Inc. since 2024.
Former roles include Chief Financial Officer & Director at PDS Biotechnology Corp.
from 2019 to 2020; Senior Vice President-Finance at Bausch Health Americas, Inc. from 2001 to 2012; Treasurer & Senior Vice President-Finance at Endo Health Solutions, Inc. from 2013 to 2014; Finance Manager at nexgenIX, Inc. from 1999 to 2001; Chief Financial Officer at Auxilium Pharmaceuticals LLC from 2014 to 2015; Chief Financial Officer at Edge Therapeutics, Inc. from 2017 to 2019; Chief Financial Officer & Treasurer at Menlo Therapeutics, Inc.; Chief Financial Officer at Vertice Pharma LLC from 2015 to 2017; Chief Financial Officer & Treasurer at VYNE Therapeutics, Inc. from 2020 to 2021; and Chief Financial Officer at Intercept Pharmaceuticals, Inc. from 2021 to 2024.
Education includes an MBA from the University of Southern California and undergraduate studies at the University of California, Los Angeles.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARVINAS, INC. 0,3% | 11/05/2026 | 193 128 ( 0,3% ) | 2 M $ | 31/05/2026 |
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Andrew Saik
| Sociétés | Poste | Début |
|---|---|---|
| ARVINAS, INC. | Directeur Financier/CFO | 24/06/2024 |
| MILESTONE PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 14/07/2024 |
Anciens postes connus de Andrew Saik
| Sociétés | Poste | Fin |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/06/2024 |
| VYNE THERAPEUTICS INC. | Directeur Financier/CFO | 18/06/2021 |
| PDS BIOTECHNOLOGY CORPORATION | Directeur Financier/CFO | 20/03/2020 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Directeur Financier/CFO | 01/03/2019 |
Vertice Pharma LLC
 Vertice Pharma LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes branded & generic prescription medicines | Directeur Financier/CFO | 01/07/2017 |
Formation de Andrew Saik
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures analgesics pharmaceutical products | Health Technology |
nexgenIX, Inc.
 nexgenIX, Inc. Packaged SoftwareTechnology Services Provides business software solutions | Technology Services |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Vertice Pharma LLC
Vertice Pharma LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes branded & generic prescription medicines | Health Technology |
PDS Biotechnology Corp.
 PDS Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers | Health Technology |
VYNE Therapeutics, Inc.
 VYNE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
